A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers ...
Weight loss drugs may be the answer to slowing cancer progression and a lower risk of death, according to new research, which ...
When physicians prescribe systemic chemotherapy, they need to strike a careful balance: the dose needs be strong enough to kill cancer cells throughout the body but not so strong that it harms healthy ...
Front Left: T. Clark Gamblin, MD, MS, MBA, FACS, Dave Harrison, His Son, Anna Harrison, (bottom right) Rachel Whitaker, RN, BSN. When Dave learned his colon cancer had returned in his liver, he became ...
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to ...
Please provide your email address to receive an email when new articles are posted on . Surgeons successfully split a deceased donor’s liver to give to two transplant recipients. One recipient, a man ...
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to ...
Please provide your email address to receive an email when new articles are posted on . Aspirin did not improve DFS for individuals with colorectal cancer liver metastases compared with placebo. OS ...
(NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today ...
The Mirror US on MSN
Surprising study finds weight loss drugs may be the answer to slowing cancer
Weight loss drugs may be the answer to slowing cancer progression and a lower risk of death, according to new research, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results